Cell & Gene Therapy Products

The Center for Biologics Evaluation and Research (CBER) controls cellular and gene therapy products and certain devices related to cell and gene therapy.  In addition to regulatory oversight of clinical studies, it also provides proactive scientific and supervisory advice to medical and clinical researchers and manufacturers in the area of novel product development.

    Related Conference of Cell & Gene Therapy Products

    June 28-30 2020

    Stroke Summit 2020

    June 15-16, 2020

    24th Global Congress on Biotechnology

    London, UK
    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    July 15-16, 2020

    25th World Biotechnology Congress

    London, UK
    September 21-22, 2020

    14th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 16-17, 2020

    International Conference on Genomics and Molecular Biology

    Lisbon, Portugal
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07-08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia

    Cell & Gene Therapy Products Conference Speakers